# Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic Dermatitis

> **NCT06039241** · — · RECRUITING · sponsor: **Sanofi** · enrollment: 900 (estimated)

## Conditions studied

- Atopic Dermatitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06039241
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-07
- **Primary completion:** 2028-03-08
- **Final completion:** 2028-03-08
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06039241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06039241, "Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic Dermatitis". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT06039241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*